1 comment

mobile_photo

Nelfinavir (Viracept®) and Ivabradine (Procoralan®, Coralan®, Corlentor®, Coraxan®, Ivabid®, Bradia®) have been added to the list of medicines with Conditional Risk of Torsades de Pointes (TdP).

View Post

1 comment

mobile_photo

Azithromycin has been associated with increased risk of death(1) and since June 2012 has been on the CredibleMeds list of QT-prolonging drugs that have “Known Risk of Torsades de Pointes (TdP).”

View Post

0 comments

mobile_photo

Research at AZCERT has documented the greater sensitivity of women to the effects of medicines that have effects on the heart and prolong the QT interval on the ECG, the influence of their menstrual cycle and the corresponding increase in life-threatening arrhythmias and deaths in women.

View Post

2 comments

CredibleMeds® is pleased to announce that My Medicines Forms, our new record-keeping and notification system, is now available.

View Post

0 comments

mobile_photo

CredibleMeds'® releases CredibleCDS™ - an open-source drug safety resource for use in clinical decision support systems.

View Post

0 comments

mobile_photo

Nature Reviews of Cardiology invited Dr. Raymond L. Woosley to author an article, assessing cardiovascular drug safety for clinical decision-making which appears in Volume 10 of the Cardiology Review.

View Post

0 comments

mobile_photo

The Annual Review of Pharmacology and Toxicology invited Dr. Raymond Woosley to author an article on the past, present and future of drug regulation which appears in Volume 53 of the Review.

View Post